QA: Biomea Fusion Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001840439_2023_Biomea_Fusion_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001840439', 'EntityCommonStockSharesOutstanding': 29396246, 'Assets': 129307000, 'AssetsCurrent': 117819000, 'ComprehensiveNetIncome': -81819000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 20768000, 'LiabilitiesAndStockholdersEquity': 129307000, 'LiabilitiesCurrent': 19101000, 'LiabilitiesNoncurrent': 1667000, 'NetIncome': -81828000, 'PropertyPlantAndEquipmentNet': 5841000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 1806000, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 5647000, 'remainder_ComprehensiveNetIncome': 9000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 108539000, 'remainder_NetIncome': -83634000, 'remainder_Revenues': 1806000, 'obs_EconomicCapitalRatio': nan}}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'100040 - Statement - Statements of Operations and Comprehensive Loss 2': 2, '100050 - Statement - Statements of Operations and Comprehensive Loss': 4}}

Edgar->Model Mapping